ArticleBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2016

A Prospective Study of Alemtuzumab as a Second-Line Agent for Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell Transplantation.

Pooja Khandelwal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.